Khaled Aamer, PhD, is a CMC and regulatory consultant with extensive experience in driving complex chemistry projects and regulatory compliance across various industries. Previously, Khaled led CMC efforts at Pfizer and held senior positions at Pall Corporation and GenapSys, where they focused on drug delivery systems and biosensor technologies. Currently, Khaled is the founder and CEO of Xgene LLC, providing consulting services in regulatory compliance and process validation. Khaled's academic credentials include multiple master's degrees in Polymer Science and Chemistry, complemented by a PhD in Polymer Science and Engineering from the University of Massachusetts Amherst.
This person is not in the org chart
This person is not in any teams
This person is not in any offices